Biotech has a problem: Too many startups, too little experience
Biotech ’s golden age is full of gray.
As new technologies accelerate the pace of biotech discoveries, the first generation of life sciences legends isn’t ceding to a new wave of entrepreneurs. Instead, young founders and old-school company creators are reaching across the generation gap.
That coopera tion could have a profound impact on how fresh ideas are spun into companies — and who pulls down ballooning venture capital rounds.
At the heart of it all is a fear that the rate of scientific…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ron Leuty Source Type: news
More News: American Health | Biotechnology | Cardiology | Health Management | Heart | Venture Capital